A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer
Clinical trial NCT05557565 · UNKNOWN
Trial details
- NCT number
- NCT05557565
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2022-10-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.